RFL – Rafael Holdings Inc
Rafael Holdings, Inc.RFL
$1.68Name : Rafael Holdings, Inc.
Sector : Real Estate
Industry: Real Estate Services
Mark. Cap: $53,835,600.00
EPSttm : -2.12
Rafael Holdings, Inc.
$1.68
5.00%$0.08Float Short %
0.78
Margin Of Safety %
Put/Call OI Ratio
0.03
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
1.68
Target Price
Analyst Recom
Performance Q
-16
Relative Volume
1.23
Beta
1.02
Ticker: RFL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | RFL | 1.96 | 0.00 | 0.00 | 220 |
| 2025-03-21 | RFL | 1.88 | 0.00 | 0.00 | 220 |
| 2025-03-24 | RFL | 1.98 | 0.00 | 0.00 | 220 |
| 2025-03-25 | RFL | 2.05 | 0.00 | 0.00 | 220 |
| 2025-03-26 | RFL | 2 | 0.02 | 0.00 | 64 |
| 2025-03-27 | RFL | 1.96 | 0.02 | 0.00 | 64 |
| 2025-03-28 | RFL | 1.93 | 0.02 | 0.00 | 64 |
| 2025-03-31 | RFL | 1.895 | 0.02 | 0.00 | 64 |
| 2025-04-01 | RFL | 1.845 | 0.02 | 0.00 | 64 |
| 2025-04-02 | RFL | 1.79 | 0.02 | 0.00 | 65 |
| 2025-04-03 | RFL | 1.835 | 0.02 | 0.00 | 65 |
| 2025-04-04 | RFL | 1.745 | 0.01 | 0.00 | 69 |
| 2025-04-07 | RFL | 1.77 | 0.01 | 0.00 | 69 |
| 2025-04-08 | RFL | 1.65 | 0.01 | 0.00 | 68 |
| 2025-04-09 | RFL | 1.7 | 0.01 | 0.00 | 68 |
| 2025-04-10 | RFL | 1.67 | 0.01 | 0.00 | 68 |
| 2025-04-11 | RFL | 1.7 | 0.01 | 0.00 | 68 |
| 2025-04-14 | RFL | 1.63 | 0.00 | 0.03 | 65 |
| 2025-04-15 | RFL | 1.625 | 0.04 | 0.00 | 290 |
| 2025-04-16 | RFL | 1.6 | 0.03 | 0.00 | 300 |
| 2025-04-17 | RFL | 1.68 | 0.03 | 0.00 | 380 |
| 2025-04-18 | RFL | 1.68 | 0.03 | 0.00 | 380 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | RFL | 1.96 | - | - | - |
| 2025-03-21 | RFL | 1.95 | - | - | - |
| 2025-03-24 | RFL | 1.98 | - | - | - |
| 2025-03-25 | RFL | 2.06 | - | - | - |
| 2025-03-26 | RFL | 1.98 | - | - | - |
| 2025-03-27 | RFL | 1.96 | - | - | - |
| 2025-03-28 | RFL | 1.90 | - | - | - |
| 2025-03-31 | RFL | 1.87 | - | - | - |
| 2025-04-01 | RFL | 1.84 | - | - | - |
| 2025-04-02 | RFL | 1.81 | - | - | - |
| 2025-04-03 | RFL | 1.81 | - | - | - |
| 2025-04-04 | RFL | 1.75 | - | - | - |
| 2025-04-07 | RFL | 1.75 | - | - | - |
| 2025-04-08 | RFL | 1.68 | - | - | - |
| 2025-04-09 | RFL | 1.70 | - | - | - |
| 2025-04-10 | RFL | 1.67 | - | - | - |
| 2025-04-11 | RFL | 1.65 | - | - | - |
| 2025-04-14 | RFL | 1.65 | - | - | - |
| 2025-04-15 | RFL | 1.62 | - | - | - |
| 2025-04-16 | RFL | 1.62 | - | - | - |
| 2025-04-17 | RFL | 1.68 | - | - | - |
| 2025-04-18 | RFL | 1.68 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | RFL | 0.00 | -1.28 | 0.51 |
| 2025-03-21 | RFL | 0.00 | -1.28 | 0.51 |
| 2025-03-24 | RFL | 0.00 | -1.29 | 0.51 |
| 2025-03-25 | RFL | 0.00 | -1.29 | 0.51 |
| 2025-03-26 | RFL | 0.00 | -1.29 | 0.64 |
| 2025-03-27 | RFL | 0.00 | -1.29 | 0.64 |
| 2025-03-28 | RFL | 0.00 | -1.29 | 0.64 |
| 2025-03-31 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-01 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-02 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-03 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-04 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-07 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-08 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-09 | RFL | 0.00 | -1.01 | 0.50 |
| 2025-04-10 | RFL | 0.00 | -1.01 | 0.78 |
| 2025-04-11 | RFL | 0.00 | -1.01 | 0.78 |
| 2025-04-14 | RFL | 0.00 | -1.01 | 0.78 |
| 2025-04-15 | RFL | 0.00 | -1.01 | 0.78 |
| 2025-04-16 | RFL | 0.00 | -1.01 | 0.78 |
| 2025-04-17 | RFL | 0.00 | -1.01 | 0.78 |
| 2025-04-18 | RFL | 0.00 | -1.01 | 0.78 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-1.01
Beta
1.02
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
41
Growth Score
39
Sentiment Score
58
Actual DrawDown %
97.5
Max Drawdown 5-Year %
-97.9
Target Price
P/E
Forward P/E
PEG
P/S
75.83
P/B
0.6
P/Free Cash Flow
EPS
-2.11
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-7148.16
Relative Volume
1.23
Return on Equity vs Sector %
-77.9
Return on Equity vs Industry %
-74.8
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Rafael Holdings, Inc.Sector: Real Estate
Industry: Real Estate Services
Employees: 28
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), a stable analog of transient, acylated catalytic intermediates of lipoate currently under phase 2 open-label multi-cohort study evaluating CPI-613 in combination with hydroxychloroquine and 5-fluorouracil or gemcitabine in patients with advanced chemorefractory colorectal, pancreatic, or other solid cancers; and under phase 1 dose-escalation study of CPI-613 in combination with chemoradiation in patients with pancreatic adenocarcinoma. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
stock quote shares RFL – Rafael Holdings Inc Stock Price stock today
news today RFL – Rafael Holdings Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch RFL – Rafael Holdings Inc yahoo finance google finance
stock history RFL – Rafael Holdings Inc invest stock market
stock prices RFL premarket after hours
ticker RFL fair value insiders trading